Trial · NCT02388165
Results by group104
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 104
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
Number of Participants With Postoperative Staphylococcus (S.) Aureus Bloodstream Infection (BSI) And/or Surgical-site Infection (SSI-Including Deep Incisional or Organ/Space) Occurred Within 90 Days After Spinal Surgery | Staphylococcus Aureus 4-antigen (SA4Ag) | 14 | Participants | ||
Number of Participants With Postoperative Staphylococcus (S.) Aureus Bloodstream Infection (BSI) And/or Surgical-site Infection (SSI-Including Deep Incisional or Organ/Space) Occurred Within 90 Days After Spinal Surgery | Placebo | 14 | Participants | ||
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Redness: Any | 9.2 | 95% Confidence Interval 7.9 to 10.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Redness: Any | 0.9 | 95% Confidence Interval 0.5 to 1.5 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Redness: Mild | 5.3 | 95% Confidence Interval 4.2 to 6.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Redness: Mild | 0.9 | 95% Confidence Interval 0.5 to 1.5 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Redness: Moderate | 3.1 | 95% Confidence Interval 2.4 to 4.1 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Redness: Moderate | 0.1 | 95% Confidence Interval 0.0 to 0.3 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Redness: Severe | 0.8 | 95% Confidence Interval 0.5 to 1.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Redness: Severe | 0.0 | 95% Confidence Interval 0.0 to 0.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Swelling: Any | 8.0 | 95% Confidence Interval 6.7 to 9.4 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Swelling: Any | 1.0 | 95% Confidence Interval 0.6 to 1.6 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Swelling: Mild | 4.6 | 95% Confidence Interval 3.6 to 5.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Swelling: Mild | 0.7 | 95% Confidence Interval 0.4 to 1.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Swelling: Moderate | 2.7 | 95% Confidence Interval 2.0 to 3.6 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Swelling: Moderate | 0.3 | 95% Confidence Interval 0.1 to 0.7 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Swelling: Severe | 0.7 | 95% Confidence Interval 0.4 to 1.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Swelling: Severe | 0.0 | 95% Confidence Interval 0.0 to 0.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Staphylococcus Aureus 4-antigen (SA4Ag) | Pain at the injection site: Any | 24.1 | 95% Confidence Interval 22.1 to 26.2 | Percentage of participants |
| Percentage of Participants With Local Reactions Within 10 Days After Vaccination | Placebo | Pain at the injection site: Any | 8.4 | 95% Confidence Interval 7.1 to 9.9 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02388165/results